These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24606786)

  • 1. In reply.
    Schott G; Pachl H; Ludwig WD; Dünnweber C; Mühlbauer B; Niebling W
    Dtsch Arztebl Int; 2014 Jan; 111(3):37-8. PubMed ID: 24606786
    [No Abstract]   [Full Text] [Related]  

  • 2. No robust argument.
    Prinz JC; Streit V
    Dtsch Arztebl Int; 2014 Jan; 111(3):35-6. PubMed ID: 24606782
    [No Abstract]   [Full Text] [Related]  

  • 3. Manipulated evidence?
    Strömer K; Reusch M
    Dtsch Arztebl Int; 2014 Jan; 111(3):36-7. PubMed ID: 24606784
    [No Abstract]   [Full Text] [Related]  

  • 4. Transparency is key.
    Follmann M
    Dtsch Arztebl Int; 2014 Jan; 111(3):37. PubMed ID: 24606785
    [No Abstract]   [Full Text] [Related]  

  • 5. Confirming the hypothesis at any cost?
    Nast A; Rzany B
    Dtsch Arztebl Int; 2014 Jan; 111(3):35. PubMed ID: 24606781
    [No Abstract]   [Full Text] [Related]  

  • 6. Information advantage or conflicts of interest?
    Kaufmann R
    Dtsch Arztebl Int; 2014 Jan; 111(3):36. PubMed ID: 24606783
    [No Abstract]   [Full Text] [Related]  

  • 7. Conflicts of interest--an ever present challenge.
    Kopp I
    Dtsch Arztebl Int; 2013 Sep; 110(35-36):573-4. PubMed ID: 24078836
    [No Abstract]   [Full Text] [Related]  

  • 8. Does the pharmaceutical industry influence guidelines?: two examples from Germany.
    Schott G; Dünnweber C; Mühlbauer B; Niebling W; Pachl H; Ludwig WD
    Dtsch Arztebl Int; 2013 Sep; 110(35-36):575-83. PubMed ID: 24078837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full disclosure.
    Maxwell D
    Can Fam Physician; 2008 Oct; 54(10):1377-8; discussion 1378. PubMed ID: 18854458
    [No Abstract]   [Full Text] [Related]  

  • 10. Financial disclosure for review authors.
    Nat Neurosci; 2003 Oct; 6(10):997. PubMed ID: 14513027
    [No Abstract]   [Full Text] [Related]  

  • 11. [Conflict of interest declarations in scientific publications].
    Möller HJ
    Nervenarzt; 2008 Sep; 79(9):1001-5. PubMed ID: 18769955
    [No Abstract]   [Full Text] [Related]  

  • 12. [Publication ethics: regulation of financial conflicts of interests in medical journals].
    Kakuk P
    Lege Artis Med; 2011 Jan; 21(1):65-71. PubMed ID: 21469379
    [No Abstract]   [Full Text] [Related]  

  • 13. Journal policies on authorship and disclosures.
    Katz PP; Yelin EH; Lockshin MD
    Arthritis Rheum; 2006 Jun; 55(3):345-7. PubMed ID: 16739200
    [No Abstract]   [Full Text] [Related]  

  • 14. Conflict of interest.
    Lewis DA; Michels R; Pine DS; Schultz SK; Tamminga CA; Freedman R
    Am J Psychiatry; 2006 Apr; 163(4):571-3. PubMed ID: 16585427
    [No Abstract]   [Full Text] [Related]  

  • 15. Getting more generous with the truth: clinical trial reporting in 2013 and beyond.
    Barbour V; Clark J; Connell L; Ross A; Simpson P; Veitch E; Winker M
    PLoS Med; 2013; 10(1):e1001379. PubMed ID: 23382657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues pertaining to the critiques of the SAINT-I Trial.
    Fisher M; Hess DC; Lees K
    Stroke; 2007 Nov; 38(11):e126-7; author reply e128. PubMed ID: 17968005
    [No Abstract]   [Full Text] [Related]  

  • 17. [Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals].
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kułakowski P; Vardas P;
    Kardiol Pol; 2012; 70(6):648-57. PubMed ID: 22718392
    [No Abstract]   [Full Text] [Related]  

  • 18. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Med Arch; 2012; 66(3):148-54. PubMed ID: 22822611
    [No Abstract]   [Full Text] [Related]  

  • 19. [Knowledge on feet of clay].
    Dahlqvist R
    Lakartidningen; 2008 May 7-13; 105(19):1405-6. PubMed ID: 18574980
    [No Abstract]   [Full Text] [Related]  

  • 20. GSK is accused of trying to suppress editorial on rosiglitazone.
    Tanne JH
    BMJ; 2010 May; 340():c2654. PubMed ID: 20484354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.